This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase δ Inhibitor, Journal of Pharmacology and Experimental Therapeutics, April 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET),
DOI: 10.1124/jpet.119.257311.
You can read the full text:
The following have contributed to this page
